Dr. Lorenzo G Cohen, a long-term associate of Dr. Nagendra in path-breaking clinical trials, explained the research findings that led to the current adoption of yoga in most US cancer hospitals. Cohen is a professor in the Department of General Oncology and Behavioral Science and the director of the Integrative Medicine Program at the University of Texas MD Anderson Cancer Center. He is also a Founding Member and past President of the Society for Integrative Oncology. He recalled his early days in mind-body research on a grant issued by National Cancer Institute of Canada when very few institutions will entertain or support his ideas. In 1997, he moved back to Houston and formed the Integrative Medicine program there in 2002. Around that time, he came into contact with the S-VYASA Yoga University and its Founder, Dr. Nagendra. “Yoga was not new to me. My grandmother was a yoga master. So, learning about Yoga University, (S-VYASA), dedicated to doing scientific research, specifically related to medicine, was a real treat and led to an incredible collaboration lasting over twenty years.” As a result of the joint research they did, they published the results of randomized trials of yoga’s impact in cancer treatment in the British Medical Journal in 2004. “Since then, we have published many trials, showing how yoga allows patients to go through cancer treatment with fewer symptoms, less anxiety and less depression, and they have a higher probability of responding to treatment,” he informed the audience. He pointed out that yoga’s role in integrative cancer care has earned a level of acceptance in the US from its main body of clinical oncologists. However, he is disappointed that there is no such support forthcoming from hospitals in Toronto, a city he loves. “A practice like yoga could save the hospital system money and that should be something that we should care about to keep the wonderful socialized medical system that we have here.” |